When I was an aspiring (much younger) scientist, one of the challenges was finding quality antibodies to accommodate our research group’s high-throughput Western blotting platform 1 while studying signaling pathways in cancer cell lines. When I got into marketing, I learned about ABclonal’s high-quality, high-specificity, and high-affinity antibody products. I really wish that I had access to these products when I was doing my thesis research! With a team of passionate, capable scientists supporting these quality products, I was thrilled at the opportunity to be part of this company and to help spread ABclonal’s brand to the scientific community.
The coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 has raised global health concerns. As case numbers continue to climb, there is an urgent need for an active drugs against SARS-CoV-2. The development of new drugs is time-consuming and costly, and the safety of new drugs is paramount. Therefore, the strategy of drug repurposing represents one of the fastest approaches to have an active drug to fight SARS-CoV-2 during the COVID-19 pandemic.
As a matter of fact, in silico repurposing approaches have found increasing popularity during the COVID-19 epidemic , especially with the great breakthrough achieved using 3CLpro as a target to screen drugs. By the end of 2021, the FDA has authorized the first oral antiviral drug Paxlovid, produced by Pfizer, to treat COVID-19. Due to that much of the scientific and clinical work on drug repurposing or drug screening against SARS-CoV-2 or COVID-19 is still ongoing, in this blog we will review the latest progress on the potential targets, including 3CLpro, for the drug discovery or intervention of COVID-19.
The cell cycle is a series of phases that takes place in a cell as it grows and divides. The cell spends most of its time in interphase. During this interphase the cell grows, replicates its chromosomes, and prepares for cell division. Once the cell leaves interphase, it will undergo the process of mitoses and start divining in order to create daughter cells. These new daughter cells will then enter their own interphase and begin a new round of the cell cycle. The cell cycle and its cues are of the utmost importance, because without the cues the cells can either multiply continuously, forming masses, or will not multiply. These cues are cyclins which controls the cell cycle progression.
The tumor is an abnormal tissue mass formed when cells divide and grow excessively within the body. Tumors can be benign (not cancerous) or malignant (cancerous). Benign tumors may become larger but do not spread to nearby tissue or other parts of the body. Malignant tumors, on the other hand, can spread nearby to tissue and can also be transmitted to other parts of the body through the blood and or lymphatic system.1 But we are no strangers to tumors and how the develop.
On the other hand, many of us aren’t as familiar with a tumor’s environment. Tumor progression is profoundly affected by the subtle interaction of tumor cells with immune and non-immune cells within their environment. In particular, the interactions with the immune cell component of a tumor are fundamental in determining whether primary tumors are eradicated, metastasized, or established by dormant micro metastases.3 The environment that a tumor grows in is also much more complex than one would think because of its highly variable cell composition, large number of proteins, and structures involved in tumor formation.
This being said, tumor microenvironment includes:
• Heterogeneous populations of cancer cells
• A variety of resident and osmotic host cells
• Secretion factors
• Extracellular matrix proteins
ABclonal has developed over 12,000 high quality antibody products since its inception in 2011. With this significant and time-tested experience, you can rest assured that ABclonal is relentless in its focus on the production and development of quality antibodies. Let’s further our understanding of antibodies by taking a more in-depth look at their structure, function, and uses in research.